Drug profile

The FDA adverse-event record for Immune System Support

12 adverse-event reports submitted to the FDA Center for Veterinary Medicine reference Immune System Support. See the species affected, top reactions, and outcomes below.

12
adverse-event reports
8.3%
death-coded share
Dog
most-reported species
3
Decreased appetite - top reaction
Verify with FDA CVM →
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
12
Total Reports
1
Deaths Reported
8.3%
Death Rate

Active Ingredients

Immune System Support

Administration Routes

UnknownOralParenteral

Species Affected

Dog 10
Cat 2

Most Affected Breeds

Shepherd Dog - German 3
Retriever - Labrador 3
Terrier - West Highland White 2
Domestic Longhair 1
Domestic Shorthair 1
Pit Bull 1
Pointer (unspecified) 1

Most Reported Reactions

Decreased appetite 3
Lethargy (see also Central nervous system depression in 'Neurological') 2
Vomiting 2
Inappropriate urination 2
Urinary tract infection 2
Decreased haemoglobin 2
Inflammatory bowel disorder 2
Musculoskeletal disorder NOS 1
Urolithiasis 1
Loss of hearing 1
Death by euthanasia 1
Walking difficulty 1

Outcome Breakdown

Ongoing
5 (41.7%)
Outcome Unknown
5 (41.7%)
Euthanized
1 (8.3%)
Recovered/Normal
1 (8.3%)

Immune System Support Adverse Event Insights

12 reports name Immune System Support; 1 recorded a death outcome (8.3% of reported events, not a population-level mortality rate). Active ingredient: Immune System Support. Administration routes: Unknown, Oral, Parenteral.

By species: Dog (10 reports), Cat (2 reports). By breed: Shepherd Dog - German (3), Retriever - Labrador (3), Terrier - West Highland White (2).

Leading clinical signs: Decreased appetite (3), Lethargy (see also Central nervous system depression in 'Neurological') (2), Vomiting (2), Inappropriate urination (2). Outcome, 12 coded reports: Ongoing leads at 41.7%.

Read these counts as reporting volume, not risk: per our methodology, a widely-prescribed drug will rack up more raw FDA reports in a given year than a rarely-used one at an identical true rate, so we recommend comparing within similar-exposure products rather than across the full 2025 catalog.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

Every figure on PlainBreed is rendered directly from FDA openFDA adverse event data, no number is typed in by an editor. This page draws directly on FDA openFDA data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.